Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Catherine M. Browne is active.

Publication


Featured researches published by Catherine M. Browne.


Nature | 2008

Sox18 induces development of the lymphatic vasculature in mice

Mathias Francois; Andrea Caprini; Brett M. Hosking; Fabrizio Orsenigo; Dagmar Wilhelm; Catherine M. Browne; Karri Paavonen; Tara Karnezis; Ramin Shayan; Meredith Downes; Tara Davidson; D. Tutt; Kathryn S. E. Cheah; Steven A. Stacker; George E. O. Muscat; Marc G. Achen; Elisabetta Dejana; Peter Koopman

The lymphatic system plays a key role in tissue fluid regulation and tumour metastasis, and lymphatic defects underlie many pathological states including lymphoedema, lymphangiectasia, lymphangioma and lymphatic dysplasia. However, the origins of the lymphatic system in the embryo, and the mechanisms that direct growth of the network of lymphatic vessels, remain unclear. Lymphatic vessels are thought to arise from endothelial precursor cells budding from the cardinal vein under the influence of the lymphatic hallmark gene Prox1 (prospero homeobox 1; ref. 4). Defects in the transcription factor gene SOX18 (SRY (sex determining region Y) box 18) cause lymphatic dysfunction in the human syndrome hypotrichosis-lymphoedema-telangiectasia, suggesting that Sox18 may also play a role in lymphatic development or function. Here we use molecular, cellular and genetic assays in mice to show that Sox18 acts as a molecular switch to induce differentiation of lymphatic endothelial cells. Sox18 is expressed in a subset of cardinal vein cells that later co-express Prox1 and migrate to form lymphatic vessels. Sox18 directly activates Prox1 transcription by binding to its proximal promoter. Overexpression of Sox18 in blood vascular endothelial cells induces them to express Prox1 and other lymphatic endothelial markers, while Sox18-null embryos show a complete blockade of lymphatic endothelial cell differentiation from the cardinal vein. Our findings demonstrate a critical role for Sox18 in developmental lymphangiogenesis, and suggest new avenues to investigate for therapeutic management of human lymphangiopathies.


Immunology and Cell Biology | 1994

Transcription of individual genes in eukaryotic cells occurs randomly and infrequently

Ian L. Ross; Catherine M. Browne; David A. Hume

Experimental evidence is presented indicating that the expression of a lacZ reporter gene driven by the HIV‐1 long terminal repeat in a series of stably transfected. cloned macrophage cell lines occurs in a very small proportion of cells. The proportion of cells expressing lacZ, rather than the level of expression in each cell, is regulated by external stimuli such as LPS and phorbol ester. Based upon these and published data we propose that transcription in eukaryotic cells occurs in short pulses interspersed by long periods of inactivity of indeterminate duration. Transcriptional regulation is envisaged as involving changes in the probability rather than the rate of transcription. A probabilistic model of transcription may explain many biological phenomena, such as stem cell division and clonogenic activity, heterogeneous gene expression among clonal cell populations, retroviral latency and cell cycle progression, which appear to involve stochastic decisions.


Development | 2009

Sox7 and Sox17 are strain-specific modifiers of the lymphangiogenic defects caused by Sox18 dysfunction in mice

Brett M. Hosking; Mathias Francois; Dagmar Wilhelm; Fabrizio Orsenigo; Andrea Caprini; Terje Svingen; D. Tutt; Tara Davidson; Catherine M. Browne; Elisabetta Dejana; Peter Koopman

Developmental defects caused by targeted gene inactivation in mice are commonly subject to strain-specific modifiers that modulate the severity of the phenotype. Although several genetic modifier loci have been mapped in mice, the gene(s) residing at these loci are mostly unidentified, and the molecular mechanisms of modifier action remain poorly understood. Mutations in Sox18 cause a variable phenotype in the human congenital syndrome hypotrichosis-lymphedema-telangiectasia, and the phenotype of Sox18-null mice varies from essentially normal to completely devoid of lymphatic vasculature and lethal, depending on the strain of the mice, suggesting a crucial role for strain-specific modifiers in this system. Here we show that two closely related Group F Sox factors, SOX7 and SOX17, are able to functionally substitute for SOX18 in vitro and in vivo. SOX7 and SOX17 are not normally expressed during lymphatic development, excluding a conventional redundancy mechanism. Instead, these genes are activated specifically in the absence of SOX18 function, and only in certain strains. Our studies identify Sox7 and Sox17 as modifiers of the Sox18 mutant phenotype, and reveal their mechanism of action as a novel mode of strain-specific compensatory upregulation.


Biology of the Cell | 2009

Functional analysis of the SRY—KRAB interaction in mouse sex determination

Juan Carlos Polanco; Dagmar Wilhelm; Hirofumi Mizusaki; Andrew Jackson; Catherine M. Browne; Tara Davidson; Vincent R. Harley; Andrew H. Sinclair; Peter Koopman

Background information. SRY (sex‐determining region Y), the master regulator of male development in mammals, has been studied extensively for more than 17 years, but how the SRY protein triggers the chain of events leading to testis development remains unclear. SRY probably requires a partner protein to elicit its molecular function. KRAB‐O, a novel protein containing a KRAB (Krüppel‐associated box) domain only, was suggested recently as a candidate SRY partner. In order to investigate the possible role of KRAB‐O in sex determination, we studied its expression and conducted functional assays of the SRY—KRAB interaction.


PLOS ONE | 2013

Loss of GGN leads to pre-implantation embryonic lethality and compromised male meiotic DNA double strand break repair in the mouse

Duangporn Jamsai; Anne O'Connor; Kathleen D. DeBoer; Brett Clark; Stephanie Smith; Catherine M. Browne; Jonathan G. Bensley; Julie A. Merriman; Wai Shan Yuen; Peter Koopman; Keith T. Jones; Moira K. O'Bryan

The integrity of male germ cell genome is critical for the correct progression of spermatogenesis, successful fertilization, and proper development of the offspring. Several DNA repair pathways exist in male germ cells. However, unlike somatic cells, key components of such pathways remain largely unidentified. Gametogenetin (GGN) is a testis-enriched protein that has been shown to bind to the DNA repair protein FANCL via yeast-two-hybrid assays. This finding and its testis-enriched expression pattern raise the possibility that GGN plays a role in DNA repair during spermatogenesis. Herein we demonstrated that the largest isoform GGN1 interacted with components of DNA repair machinery in the mouse testis. In addition to FANCL, GGN1 interacted with the critical component of the Fanconi Anemia (FA) pathway FANCD2 and a downstream component of the BRCA pathway, BRCC36. To define the physiological function of GGN, we generated a Ggn null mouse line. A complete loss of GGN resulted in embryonic lethality at the very earliest period of pre-implantation development, with no viable blastocysts observed. This finding was consistent with the observation that Ggn mRNA was also expressed in lower levels in the oocyte and pre-implantation embryos. Moreover, pachytene spermatocytes of the Ggn heterozygous knockout mice showed an increased incidence of unrepaired DNA double strand breaks (DSBs). Together, our results suggest that GGN plays a role in male meiotic DSB repair and is absolutely required for the survival of pre-implantation embryos.


PLOS ONE | 2011

Tmem26 is dynamically expressed during palate and limb development but is not required for embryonic survival.

Liam Town; Edwina McGlinn; Tara-Lynne Davidson; Catherine M. Browne; Kallayanee Chawengsaksophak; Peter Koopman; Joy M. Richman; Carol Wicking

The Tmem26 gene encodes a novel protein that we have previously shown to be regulated by hedgehog signalling in the mouse limb. We now report that Tmem26 expression is spatially and temporally restricted in other regions of the mouse embryo, most notably the facial primordia. In particular, Tmem26 expression in the mesenchyme of the maxillary and nasal prominences is coincident with fusion of the primary palate. In the secondary palate, Tmem26 is expressed in the palatal shelves during their growth and fusion but is downregulated once fusion is complete. Expression was also detected at the midline of the expanding mandible and at the tips of the eyelids as they migrate across the cornea. Given the spatio-temporally restricted expression of Tmem26, we sought to uncover a functional role in embryonic development through targeted gene inactivation in the mouse. However, ubiquitous inactivation of Tmem26 led to no overt phenotype in the resulting embryos or adult mice, suggesting that TMEM26 function is dispensable for embryonic survival.


Cell and Tissue Research | 2005

Genetic basis of human testicular germ cell cancer: insights from the fruitfly and mouse

Catherine M. Browne; Gary R. Hime; Peter Koopman; Kate L. Loveland

The prevalence of tumours of the germ line is increasing in the male population. This complex disease has a complex aetiology. We examine the contribution of genetic mutations to the development of germ line tumours in this review. In particular, we concentrate on fly and mouse experimental systems in order to demonstrate that mutations in some conserved genes cause pathologies typical of certain human germ cell tumours, whereas other mutations elicit phenotypes that are unique to the experimental model. Despite these experimental systems being imperfect, we show that they are useful models of human testicular germ cell tumourigenesis.


Blood | 1999

Differentiation of the Mononuclear Phagocyte System During Mouse Embryogenesis: The Role of Transcription Factor PU.1

Agnieszka M. Lichanska; Catherine M. Browne; Gregory W. Henkel; Kathleen M. Murphy; Michael C. Ostrowski; Scott R. McKercher; Richard A. Maki; David A. Hume


Immunobiology | 1996

Transcriptional Control of the Expression of the c-fms Gene Encoding the Receptor for Macrophage Colony-Stimulating Factor (CSF-1)

Xie Yue; Ian L. Ross; Catherine M. Browne; Agnieszka M. Lichanska; Paula Favot; Michael C. Ostrowski; David A. Hume


Archive | 1996

Growth and differentiation of murine macrophages

David A. Hume; Katryn J. Stacey; A. I. Cassady; Catherine M. Browne; Matthew J. Sweet; I. Bertoncello

Collaboration


Dive into the Catherine M. Browne's collaboration.

Top Co-Authors

Avatar

Peter Koopman

University of Queensland

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ian L. Ross

University of Queensland

View shared research outputs
Top Co-Authors

Avatar

Tara Davidson

University of Queensland

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. Tutt

University of Queensland

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Xie Yue

University of Queensland

View shared research outputs
Researchain Logo
Decentralizing Knowledge